The U.S. Food and Drug Administration (FDA) initially made the Spikevax (Moderna), Comirnaty (Pfizer), Novavax and Johnson & Johnson (Janssen) COVID-19 vaccines available during the current public health emergency using an Emergency Use Authorization (EUA) (https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines). The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that “circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic.” The FDA’s decision is based on scientific evidence showing the vaccines are effective to prevent COVID-19 and that the benefits of the products outweigh the risks.